X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.reuters.com/legal/sanofi-settle-4000-zantac-cancer-lawsuits-us-state-courts-2024-04-03/
https://www.fiercepharma.com/pharma/trial-neared-gsk-inked-another-zantac-settlement-california
https://www.reuters.com/legal/fate-most-remaining-zantac-lawsuits-weighed-by-delaware-judge-2024-01-22/
https://www.reuters.com/legal/gsk-reaches-confidential-settlement-california-zantac-lawsuit-2023-10-11/
https://www.fiercepharma.com/pharma/astrazeneca-ponies-425m-settle-us-lawsuits-over-nexium-prilosec
https://endpts.com/gsk-announces-key-zantac-case-settlement-in-ca-state-court/
https://www.reuters.com/legal/gsk-reaches-settlement-us-zantac-litigation-2023-06-23/?rpc=401&
https://www.fiercepharma.com/pharma/ahead-upcoming-california-trial-gsk-notches-win-canadian-zantac-litigation
https://www.reuters.com/legal/gsk-disagrees-with-california-court-ruling-zantac-litigation-shares-down-4-2023-03-24/
https://www.fiercepharma.com/pharma/will-fda-investigate-gsk-over-zantac-rep-delauro-wants-know
https://health.economictimes.indiatimes.com/news/pharma/first-zantac-cancer-risk-trial-in-california-postponed-by-months/98201405
https://www.fiercepharma.com/pharma/gsks-first-state-level-zantac-trial-delayed-judge-reviews-science-both-sides-argument-report
https://www.fiercepharma.com/pharma/gsk-was-warned-repeatedly-about-zantac-risks-didnt-act-warnings-bloomberg
https://medicaldialogues.in/news/industry/pharma/cancer-litigation-over-zantac-us-court-gives-relief-to-pharma-cos-dismisses-thousands-of-lawsuits-103621
https://www.fiercepharma.com/pharma/gsk-sanofi-pfizer-and-boehringer-ingelheim-free-federal-zantac-litigation-new-ruling
https://endpts.com/florida-judge-dismisses-zantac-cancer-claims-against-gsk-other-pharmas/
https://www.reuters.com/article/gsk-zantac-sanofi/gsk-sanofi-shares-soar-as-zantac-litigation-fears-abate-idUSKBN2SR0QX
https://www.fiercepharma.com/pharma/zantac-litigation-state-level-companies-face-claims-other-cancer-types-not-covered-federal
https://www.fiercepharma.com/pharma/haleon-sees-revenue-growth-after-gsk-spin-out-rejects-zantac-litigation-claims
https://endpts.com/a-month-after-gsks-win-in-zantac-cancer-case-plaintiffs-file-dozens-more-suits/
https://www.bnnbloomberg.ca/sanofi-and-gsk-lead-30-billion-rout-as-zantac-worries-mount-1.1804396
https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-sanofi-haleon-shares-stabilise-after-zantac-litigation-slump-2022-08-12/
https://www.fiercepharma.com/pharma/market-reaction-sanofis-upcoming-litigation-over-zantac-overblown-analysts-say
https://www.fiercepharma.com/marketing/jj-lambasts-sanofi-zantac-marketing-claims-pharmas-icyhot-pain-patch-campaign-also
https://www.fiercepharma.com/pharma/sanofi-gsk-pfizer-and-boehringer-must-face-zantac-class-action-lawsuits-court-rules
https://endpts.com/industry-groups-warn-of-drug-shortages-linked-to-widespread-carcinogen-testing-as-fda-doubles-down-on-its-approach/
https://endpts.com/zantac-manufacturers-off-the-hook-after-judge-dismisses-negligence-and-failure-to-warn-claims-in-class-action-lawsuit/
https://www.bloombergquint.com/onweb/sanofi-accused-of-destroying-internal-emails-about-zantac-recall
https://www.druganddevicelawblog.com/2021/02/zantac-chronicles-no-innovative-or-innovator-liability.html
https://www.pharmacompass.com/pdf/news/health-canada-pharmascience-increcalls-of-pms-ranitidine-150mg-1612589331.pdf
https://www.fiercepharma.com/pharma/valisure-links-unstable-zantac-and-its-ilk-to-carcinogen-build-up-cancer-risk
https://www.pharmacompass.com/pdf/news/health-canada-issue-recall-of-pharmascience-incs-acid-reducer-1610521195.pdf
https://www.law360.com/lifesciences/articles/1338197?utm_source=rss&utm_medium=rss&utm_campaign=section
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-sandoz-canadas-ranitidine-injection-usp-1598849989.pdf
https://www.fiercepharma.com/pharma/sanofi-glaxosmithkline-disclose-doj-probe-into-zantac-disclosures
https://www.prnewswire.com/news-releases/plaintiffs-leadership-files-personal-injury-and-class-action-complaints-in-zantacranitidine-products-liability-mdl-301082484.html
https://www.fiercepharma.com/manufacturing/amneal-yanks-nazitidine-solution-off-u-s-shelves-fears-possible-carcinogen
https://www.raps.org/news-and-articles/news-articles/2020/4/fda-seeks-withdrawal-of-heartburn-drugs-due-to-new
https://www.fiercepharma.com/manufacturing/zantac-and-generics-ordered-off-market-by-fda-as-find-it-a-ticking-time-bomb
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-12-2020-1581485052.pdf
https://www.fiercepharma.com/manufacturing/sanofi-takes-a-big-financial-hit-after-recall-contaminated-zantac
https://www.fiercepharma.com/manufacturing/more-generic-zantac-recalled-as-ndma-contamination-concerns-build
https://www.fiercepharma.com/pharma/stop-and-plan-it-out-sanofi-ceo-paul-hudson-has-some-tips-for-pharma-s-technology-ambitions
https://www.pharmacompass.com/pdf/news/appco-pharma-llc-issues-voluntary-nationwide-recall-of-ranitidine-hydrochloride-capsules-150-mg-and-300-mg-1578472591.pdf
https://www.raps.org/news-and-articles/news-articles/2020/1/high-carcinogen-levels-cause-another-ranitidine-re
https://www.raps.org/news-and-articles/news-articles/2020/1/high-carcinogen-levels-cause-another-ranitidine-re
https://www.raps.org/news-and-articles/news-articles/2020/1/high-carcinogen-levels-cause-another-ranitidine-re
https://www.fiercepharma.com/manufacturing/lab-finds-ndma-zantac-can-develop-during-storage-bloomberg
https://www.fiercepharma.com/pharma/how-biopharma-industry-like-a-sitcom-a-word-complexity
Market Place
Share 
